These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Benzathine penicillin G once-every-3-week prophylaxis for recurrent erysipelas a retrospective study of 132 patients. Rob F; Hercogová J J Dermatolog Treat; 2018 Feb; 29(1):39-43. PubMed ID: 28489486 [TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with a reduced response in the treatment of erysipelas. Linke M; Booken N J Dtsch Dermatol Ges; 2015 Mar; 13(3):217-25. PubMed ID: 25706926 [TBL] [Abstract][Full Text] [Related]
6. [Bacterial dermohypodermitis and necrotizing fascitis: 104-case series from Togo]. Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Boukari T; Pitché P; Tchangaï-Walla K Med Trop (Mars); 2011 Apr; 71(2):162-4. PubMed ID: 21695874 [TBL] [Abstract][Full Text] [Related]
7. [Epidemiology, clinical features, and evolution of Erysipelas in the Marrakech region (100 cases)]. Amal S; Houass S; Laissaoui K; Moufid K; Trabelsi M Med Mal Infect; 2004 Apr; 34(4):171-6. PubMed ID: 15619888 [TBL] [Abstract][Full Text] [Related]
8. [Erysipelas at the dermatological clinic in Mannheim 1960-1975]. Bertsch O; Bojanovsky A; Jung EG Z Hautkr; 1977 Sep; 52(17):885-9. PubMed ID: 910535 [TBL] [Abstract][Full Text] [Related]
9. [Principles of treatment of patients with recurrent erysipelas]. Cherkasov VL; Samotolkin KN Vrach Delo; 1983 Feb; (2):113-6. PubMed ID: 6845687 [No Abstract] [Full Text] [Related]
10. History of diagnostics in dermatovenerology on Medical Faculty in Prague. Kruzicová Z Prague Med Rep; 2009; 110(2):159-64. PubMed ID: 19591390 [TBL] [Abstract][Full Text] [Related]
11. [Erysipelas in the young population of a military hospital]. Mahé E; Toussaint P; Lamarque D; Boutchnei S; Guiguen Y Ann Dermatol Venereol; 1999; 126(8-9):593-9. PubMed ID: 10530346 [TBL] [Abstract][Full Text] [Related]
12. Changing patterns of erysipelas. Shimoni Z; Turgeman Y; Flatau E; Kohn D Isr J Med Sci; 1984 Mar; 20(3):242-3. PubMed ID: 6724870 [No Abstract] [Full Text] [Related]
13. [Effectiveness in treating patients with different clinical forms of erysipelas]. Kriukova ZV; Kriukova SA; Panichkina LN Vrach Delo; 1986 Aug; (8):121-2. PubMed ID: 3776149 [No Abstract] [Full Text] [Related]
14. [Clinico-immunological evaluation of antibiotic thereapy and prevention of frequent recurrences of erysipelas]. Cherkasov VL; Iakhontova NK; Chistenkov NA Klin Med (Mosk); 1974 Feb; 52(2):52-7. PubMed ID: 4466916 [No Abstract] [Full Text] [Related]
15. Recurrent erysipelas--risk factors and clinical presentation. Inghammar M; Rasmussen M; Linder A BMC Infect Dis; 2014 May; 14():270. PubMed ID: 24884840 [TBL] [Abstract][Full Text] [Related]
16. Erysipelas after breast cancer treatment. Naveen KN; Pai VV; Sori T; Kalabhavi S Breast; 2012 Apr; 21(2):218-9. PubMed ID: 21925882 [No Abstract] [Full Text] [Related]
17. [Treatment of erysipelas by directed abacterial means]. Liapis MO; Andreĭchin SM; Checheniuk OI Klin Khir; 1996; (1):16-7. PubMed ID: 8768198 [No Abstract] [Full Text] [Related]
19. [Clinical picture of erysipelas based on material from the Department of Dermatology of the Academy of Medicine in Cracow in 1957-1966]. Kowarz-Sokolowska H; Duszkiewicz J; Malecka A Przegl Dermatol; 1969; 56(5):619-25. PubMed ID: 5362102 [No Abstract] [Full Text] [Related]
20. [Erysipelas and cellulitis: a retrospective study of 122 cases]. Concheiro J; Loureiro M; González-Vilas D; García-Gavín J; Sánchez-Aguilar D; Toribio J Actas Dermosifiliogr; 2009 Dec; 100(10):888-94. PubMed ID: 20038366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]